Weekly shot may help those with both type 1 and type 2 diabetes traits
NCT ID NCT05305794
First seen Jan 04, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tests if a weekly injection of semaglutide (a GLP1 drug used for type 2 diabetes) can help people with 'double diabetes' — a mix of type 1 diabetes and inherited insulin resistance. About 76 adults with type 1 diabetes, a BMI of 27 or higher, and a family history of type 2 diabetes will receive either semaglutide or standard care. The goal is to see if the drug increases the time their blood sugar stays in a healthy range.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOUBLE DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.